636 related articles for article (PubMed ID: 7896216)
21. Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid.
Zhang GS; Zuo WL; Dai CW; Xu YX; Shen JK; Luo YY; Yi Y
Thromb Haemost; 2006 Nov; 96(5):692-4. PubMed ID: 17080230
[No Abstract] [Full Text] [Related]
22. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident.
Mansouritorghabeh H; Lak M; van Heerde WL
Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586
[TBL] [Abstract][Full Text] [Related]
23. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
24. Current management of acquired factor VIII inhibitors.
Barnett B; Kruse-Jarres R; Leissinger CA
Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
[TBL] [Abstract][Full Text] [Related]
25. Advances in the understanding of acquired haemophilia A: implications for clinical practice.
Collins PW; Percy CL
Br J Haematol; 2010 Jan; 148(2):183-94. PubMed ID: 19814739
[TBL] [Abstract][Full Text] [Related]
26. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
27. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
[TBL] [Abstract][Full Text] [Related]
28. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients.
Prentice CR
Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428
[No Abstract] [Full Text] [Related]
29. Inhibitors to factor VIII:C in nonhemophiliacs.
Milica CD; Gradimir JM; Nada S; Radoje CB
Am J Hematol; 1996 May; 52(1):61. PubMed ID: 8638615
[No Abstract] [Full Text] [Related]
30. [Acquired hemophilia: current diagnostic and therapeutic approaches].
Lévesque H; Borg JY; Bossi P; Goudemand J; Guillet B; Cabane J
Rev Med Interne; 2001 Sep; 22(9):854-66. PubMed ID: 11599187
[TBL] [Abstract][Full Text] [Related]
31. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
Sucker C; Michiels JJ; Zotz RB
Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM
N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653
[TBL] [Abstract][Full Text] [Related]
33. [Immune coagulation disorders (excluding antiphospholipid syndrome].
Arai M
Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
[TBL] [Abstract][Full Text] [Related]
34. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
[TBL] [Abstract][Full Text] [Related]
35. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
Hertzberg MS; Favaloro E; Koutts J
Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
[No Abstract] [Full Text] [Related]
36. [Acquired factor VIII deficiency treated with cyclosporine].
Leinøe EB; Jørgensen M; Nielsen JD
Ugeskr Laeger; 1999 Aug; 161(34):4762-3. PubMed ID: 10500467
[TBL] [Abstract][Full Text] [Related]
37. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
Walsh JD; Landercasper J; Bottner WA; Boyd WC
Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
[TBL] [Abstract][Full Text] [Related]
38. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
Sahu S; Raipancholia R; Pardiwalla FK; Pathare AV
J Postgrad Med; 1996; 42(3):88-90. PubMed ID: 9715327
[TBL] [Abstract][Full Text] [Related]
39. Recent improvements in the clinical treatment of coagulation factor inhibitors.
Franchini M; Lippi G
Semin Thromb Hemost; 2009 Nov; 35(8):806-13. PubMed ID: 20169517
[TBL] [Abstract][Full Text] [Related]
40. Treatment of inhibitor patients with activated prothrombin complex concentrates.
Penner JA
Prog Clin Biol Res; 1984; 150():291-308. PubMed ID: 6431434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
